O'Hare Ann M, Bertenthal Daniel, Shlipak Michael G, Sen Saunak, Chren Mary-Margaret
Division of Nephrology, Box 111J, Nephrology, VA Medical Center San Francisco, 4150 Clement Street, San Francisco, CA 94121, USA. Ann.O'
J Am Soc Nephrol. 2005 Feb;16(2):514-9. doi: 10.1681/ASN.2004050409. Epub 2004 Dec 15.
Renal insufficiency predicts mortality among patients who are treated for myocardial infarction and congestive heart failure, but its clinical significance in advanced peripheral arterial disease has not been evaluated. A national cohort of 5787 male veterans who received an initial diagnosis of rest pain, ischemic ulceration, or gangrene between January 1, 2000, and September 30, 2002, and had at least one serum creatinine measurement within 3 mo before diagnosis were identified. Sixty-two percent (n = 3561) of cohort members had normal or mildly reduced renal function (GFR > or =60 ml/min per 1.73 m(2)), 30% (n = 1742) had moderate renal insufficiency (GFR 30 to 59 ml/min per 1.73 m(2)), and 8% (n = 484) had severe renal insufficiency or renal failure (GFR <30 ml/min per 1.73 m(2)) but were not on dialysis. The percentages of patients who presented with gangrene or ischemic ulceration rather than rest pain increased with declining renal function (70, 77, and 87%; P < 0.001), as did 1-yr mortality risk (17, 27, and 44%; P < 0.001). After adjustment for demographic and clinical characteristics, patients with a GFR of 30 to 59 ml/min per 1.73 m(2) (odds ratio, 1.32; 95% confidence interval, 1.13 to 1.53) and <30 ml/min per 1.73 m(2) (odds ratio, 2.97; 95% confidence interval, 2.39 to 3.69) had a significantly increased odds of death within 1 yr of cohort entry. Both moderate and severe renal insufficiency are associated with an increased odds of death in patients with critical limb ischemia. Death rates were particularly high among those with a GFR <30 ml/min per 1.73 m(2). This finding may be partly explained by their more frequent presentation with ischemic ulceration or gangrene rather than rest pain.
肾功能不全可预测接受心肌梗死和充血性心力衰竭治疗患者的死亡率,但其在晚期外周动脉疾病中的临床意义尚未得到评估。确定了一个全国性队列,其中5787名男性退伍军人在2000年1月1日至2002年9月30日期间首次被诊断为静息痛、缺血性溃疡或坏疽,且在诊断前3个月内至少进行过一次血清肌酐测量。队列成员中62%(n = 3561)肾功能正常或轻度降低(肾小球滤过率[GFR]≥60 ml/(min·1.73 m²)),30%(n = 1742)有中度肾功能不全(GFR为30至59 ml/(min·1.73 m²)),8%(n = 484)有严重肾功能不全或肾衰竭(GFR<30 ml/(min·1.73 m²))但未接受透析。出现坏疽或缺血性溃疡而非静息痛的患者百分比随肾功能下降而增加(分别为70%、77%和87%;P<0.001),1年死亡风险也是如此(分别为17%、27%和44%;P<0.001)。在对人口统计学和临床特征进行调整后,GFR为30至59 ml/(min·1.73 m²)的患者(比值比,1.32;95%置信区间,1.13至1.53)和GFR<30 ml/(min·1.73 m²)的患者(比值比,2.97;95%置信区间,2.39至3.69)在进入队列后1年内死亡几率显著增加。中度和重度肾功能不全均与严重肢体缺血患者的死亡几率增加相关。GFR<30 ml/(min·1.73 m²)的患者死亡率尤其高。这一发现可能部分归因于他们更常出现缺血性溃疡或坏疽而非静息痛。